Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

PHER-O2 completes animal toxicity and efficacy trials at U. of Alberta

Nov. 19, 2004

Safety labeling changes for mifepristone

Nov. 19, 2004

Rosuvastatin significantly improves hypercholesterolemia in African Americans

Nov. 18, 2004

Scientists at AmorePacific claim genistein for the treatment of obesity

Nov. 18, 2004

Nesterone MDTS contraceptive spray enters clinical testing

Nov. 18, 2004

Fast track status for XP-12B for menorrhagia

Nov. 18, 2004

Australian phase II study of Testosterone MDTS completed

Nov. 18, 2004

GW-501516 increases HDL-cholesterol levels in healthy volunteers

Nov. 17, 2004

Enrollment closes in Chinese Femprox study

Nov. 17, 2004

PDE5 inhibitors for the treatment of diabetes

Nov. 16, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...